Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro. - Akamatsu,H.; Zouboulis,CC.; Orfanos,CE. (J Invest Dermatol, 1993)